Used primarily in pharmaceutical research as an intermediate in the synthesis of drugs targeting central nervous system disorders. The synthesized compounds exhibit affinity for serotonin and dopamine receptors, making them valuable in developing treatments for psychiatric conditions such as schizophrenia and depression. Its structure allows for modification to enhance selectivity and potency in receptor binding, which is crucial in creating more effective and safer neuropsychiatric medications. The final compounds are also investigated for potential use in treating cognitive impairments due to their interaction with neurotransmitter pathways involved in memory and learning.